ATRC (AtriCure) FFO


ATRC AtriCure Inc ATRC
76 GF Score
Price $28.26
GF Value $39.73
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is AtriCure FFO?

FFO (Funds from operations) only applies to REITs.

ATRC
76GF Score
AtriCure Inc ATRC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtriCure (ATRC) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be undervalued. The current stock price of $28.26 is trading 28.9% below its estimated GF Value™ of $39.73. GuruFocus considers AtriCure to be Modestly Undervalued.

Key valuation signals for ATRC:

  • FFO:
  • GF Value™: $39.73 vs. price of $28.26 (28.9% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the ATRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtriCure Business Description

Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
76GF Score

Get the complete analysis for ATRC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.26
Price
$39.73
GF Value